Skip to main content

Table 1 The clinical information of bladder cancer tumor samples in the training set and validation set

From: A potential prognostic model based on miRNA expression profile in The Cancer Genome Atlas for bladder cancer patients

Clinical characteristics Training set (N = 204) Validation set (N = 205)
Age (years, mean ± SD) 68.46 ± 27.57 67.69 ± 9.86
Gender (male/female) 154/50 148/57
Pathologic M (M0/M1/–) 99/7/98 96/4/105
Pathologic N (N0/N1/N2/N3/–) 122/23/36/2/21 115/23/40/6/21
Pathologic T (T1/T2/T3/T4/–) 3/65/95/27/14 1/55/99/31/19
Pathologic stage (I/II/III/IV/–) 2/71/65/65/1 0/60/74/70
Pathologic grade (high/low/–) 194/9/1 191/12/2
Radiotherapy (yes/no/–) 6/186/12 14/177/14
Lymphovascular invasion (yes/no/–) 65/73/66 85/59/61
Recurrence (yes/no) 44/126/34 43/124/38
Dead (death/alive/–) 92/110/2 86/117/2
Overall survival time (months, mean ± SD) 26.76 ± 27.57 27.45 ± 28.19
  1. M distant metastases, N regional lymph node, T tumor size